Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu, Dwight V. Nissley, Frank McCormick
Cell (2017) Vol. 170, Iss. 1, pp. 17-33
Open Access | Times Cited: 1576

Showing 1-25 of 1576 citing articles:

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon, Karen Rex, Anne Y. Saiki, et al.
Nature (2019) Vol. 575, Iss. 7781, pp. 217-223
Closed Access | Times Cited: 1803
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong, Marwan Fakih, John H. Strickler, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 13, pp. 1207-1217
Open Access | Times Cited: 1365
ERK/MAPK signalling pathway and tumorigenesis (Review)
Yanjun Guo, Weiwei Pan, Shengbing Liu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 1198
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin, Lars D. Engstrom, Lauren Hargis, et al.
Cancer Discovery (2019) Vol. 10, Iss. 1, pp. 54-71
Open Access | Times Cited: 1064
A compendium of mutational cancer driver genes
Francisco Martínez-Jiménez, Ferran Muiños, Inés Sentís, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 10, pp. 555-572
Closed Access | Times Cited: 996
The Frequency of Ras Mutations in Cancer
Ian A. Prior, Fiona E. Hood, James L. Hartley
Cancer Research (2020) Vol. 80, Iss. 14, pp. 2969-2974
Open Access | Times Cited: 785
Autophagy and autophagy-related pathways in cancer
Jayanta Debnath, Noor Gammoh, Kevin M. Ryan
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 8, pp. 560-575
Open Access | Times Cited: 652
The tumor suppressor protein p53 and the ferroptosis network
Rui Kang, Guido Kroemer, Daolin Tang
Free Radical Biology and Medicine (2018) Vol. 133, pp. 162-168
Open Access | Times Cited: 542
Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein
Enyong Dai, Leng Han, Jiao Liu, et al.
Autophagy (2020) Vol. 16, Iss. 11, pp. 2069-2083
Open Access | Times Cited: 460
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
Jay B. Fell, John P. Fischer, Brian R. Baer, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 13, pp. 6679-6693
Open Access | Times Cited: 458
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
Xiaolun Wang, Shelley Allen, James F. Blake, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 3123-3133
Open Access | Times Cited: 452
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Ufuk Degirmenci, Mei Wang, Jiancheng Hu
Cells (2020) Vol. 9, Iss. 1, pp. 198-198
Open Access | Times Cited: 451
Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression
Jan Ježek, Katrina F. Cooper, Randy Strich
Antioxidants (2018) Vol. 7, Iss. 1, pp. 13-13
Open Access | Times Cited: 434
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
Jenny Y. Xue, Yulei Zhao, Jordan Aronowitz, et al.
Nature (2020) Vol. 577, Iss. 7790, pp. 421-425
Open Access | Times Cited: 429
Signaling pathways and defense mechanisms of ferroptosis
Jiao Liu, Rui Kang, Daolin Tang
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 7038-7050
Open Access | Times Cited: 412
Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
Sergey I. Nikolaev, Sandra Vetiska, Ximena Bonilla, et al.
New England Journal of Medicine (2018) Vol. 378, Iss. 3, pp. 250-261
Open Access | Times Cited: 397
AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection
Thomas Vierbuchen, Emi Ling, Christopher Cowley, et al.
Molecular Cell (2017) Vol. 68, Iss. 6, pp. 1067-1082.e12
Open Access | Times Cited: 388
Targeting Alterations in the RAF–MEK Pathway
Rona Yaeger, Ryan B. Corcoran
Cancer Discovery (2019) Vol. 9, Iss. 3, pp. 329-341
Open Access | Times Cited: 375
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Outi M. H. Salo‐Ahen, Ida Alanko, Rajendra Bhadane, et al.
Processes (2020) Vol. 9, Iss. 1, pp. 71-71
Open Access | Times Cited: 373
Clinical management of metastatic colorectal cancer in the era of precision medicine
Fortunato Ciardiello, Davide Ciardiello, Giulia Martini, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 4, pp. 372-401
Open Access | Times Cited: 370
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
Vito Amodio, Rona Yaeger, Pamela Arcella, et al.
Cancer Discovery (2020) Vol. 10, Iss. 8, pp. 1129-1139
Open Access | Times Cited: 361
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan, Ryan B. Corcoran
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 11, pp. 709-720
Closed Access | Times Cited: 340
Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
Michael J. Bond, Ling Chu, Dhanusha A. Nalawansha, et al.
ACS Central Science (2020) Vol. 6, Iss. 8, pp. 1367-1375
Open Access | Times Cited: 327
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
R.C. Hillig, Brice Sautier, Jens Schroeder, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 7, pp. 2551-2560
Open Access | Times Cited: 325
A model for RAS mutation patterns in cancers: finding the sweet spot
Siqi Li, Allan Balmain, Christopher M. Counter
Nature reviews. Cancer (2018) Vol. 18, Iss. 12, pp. 767-777
Closed Access | Times Cited: 324
Page 1 - Next Page

Scroll to top